Trade Info : Orchid Pharma released financial results with mixed audit opinions on its reports

Symbol

ORCHPHARMA

Company

Orchid Pharma Ltd

Category

Financial

Source

Stock Exchange Filing

2054.70

191091.19

4.05

128778.60

News Summary

Orchid Pharma Ltd released its audited financial results for the year ended March 31, 2026.
The company received a clean audit opinion for its standalone results but a qualified opinion for consolidated results.
The board also appointed a new internal auditor for the upcoming financial year.

Why This Matters

This means investors need to understand why some parts of the financial report were not fully audited.
As a result, there is a small risk that some overseas subsidiary numbers might not be fully checked.
Investors should know that the main Indian operations are audited cleanly and look healthy.

Fundamental Backdrop (FY – FY 2026)

Metric	Value
Net Profit For The Year
Total Assets
Total Equity
Earnings Per Share

Analyst's View

This suggests the company is growing its business while managing global operations.
The company appears to be expanding its manufacturing and acquiring new technology.
Investors may want to watch how the company handles its overseas subsidiaries.

Buy

Confidence 75%

Conviction Level 75%

The company shows solid profits and growth in its main business, even though some overseas parts are not fully audited.

Key Positives

Standalone financial results received a clean audit opinion showing strong internal controls.
Net profit for the year ended March 2026 was 2,054.70 lakhs indicating healthy earnings.
The company successfully completed major acquisitions to consolidate its antibiotic business.

Key Risks

Consolidated results have a qualified audit opinion due to unaudited US subsidiary reports.
Some overseas subsidiaries have zero revenue reported which raises transparency questions.
The company has significant debt which could limit future expansion plans.

HorizonMedium

Confidence LevelMedium

Suggested position size: Maintain current holdings with a watch on future audit outcomes

⚠️

Disclaimer This analysis is for informational purposes only and does not constitute financial advice. Do your own research and consult a qualified financial professional before making any investment decisions.